Drug Profile
CGP 7040
Latest Information Update: 01 Sep 1994
Price :
$50
*
At a glance
- Originator Novartis
- Class Antibacterials
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycobacterium avium complex infections